Reduced Thrombin Formation and Altered Fibrin Clot Properties Induced by Polyunsaturated Omega-3 Fatty Acids on Top of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention (OMEGA-PCI Clot)
Author(s) -
Grzegorz Gajos,
J Zalewski,
Paweł Rostoff,
Jadwiga Nessler,
W Piwowarska,
Anetta Undas
Publication year - 2011
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.111.228593
Subject(s) - fibrinogen , medicine , percutaneous coronary intervention , fibrin , polyunsaturated fatty acid , thrombin , fibrinolysis , conventional pci , placebo , cardiology , gastroenterology , myocardial infarction , immunology , chemistry , pathology , platelet , biochemistry , fatty acid , alternative medicine
The goal of this study was to investigate whether omega-3 polyunsaturated fatty acids (n-3 PUFA) are able to alter plasma fibrin clot properties and reduce thrombin formation in stable coronary artery disease patients undergoing percutaneous coronary intervention (PCI).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom